THE CIGNA GROUP AND SUBSIDIARIES (FORMERLY CIGNA CORPORATION AND SUBSIDIARIES)

Lobbying for THE CIGNA GROUP AND SUBSIDIARIES (FORMERLY CIGNA CORPORATION AND SUBSIDIARIES)

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $3,460,000.00 expenses · posted Apr 21, 2025

Official filing document

Bills named in this filing 14

HR 4189
To direct the Secretary of the Navy to recognize certain aspects of the National Navy UDT-SEAL Museum in Fort Pierce, F…
S 2016
Chugach Alaska Land Exchange Oil Spill Recovery Act of 2025
S 864
HELP Copays Act
HR 247
Health Care Affordability Act of 2025
HR 2214
DRUG Act
S 526
Pharmacy Benefit Manager Transparency Act of 2025
S 1040
Drug Competition Enhancement Act
S 1041
Affordable Prescriptions for Patients Act
HCONRES 14
Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appro…
SCONRES 7
An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal ye…
HR 1968
Full-Year Continuing Appropriations and Extensions Act, 2025
S 1542
DRUG Act
HR 5378
Lower Costs, More Transparency Act
S 1339
Pharmacy Benefit Manager Reform Act

Lobbying activity 5

Medicare/Medicaid

P.L. 117-169, the Inflation Reduction Act of 2022; H.R. 4189/S. 2016, The Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2023.

Health Issues

S. 864/H.R. 247, the Health Care Affordability Act of 2025 and issues relating to extension of Enhanced Advanced Premium Tax Credits (EAPTCs) included in the American Rescue Plan Act (ARPA) and the Inflation Reduction Act (IRA).

Defense

Pharmacy issues related to the National Defense Authorization Act, FY2026.

Pharmacy

S. 1542/H.R.2214, the DRUG Act; H.R. 5378 Lower Costs, More Transparency Act; S. 1339, Pharmacy Benefit Manager Reform Act; S. 526, Pharmacy Benefit Manager Transparency Act; S. 1040, The Drug Competition and Enhancement Act; S. 1041, The Affordable Prescriptions for Patients Act.

Budget/Appropriations

Issues related to H.Con.Res. 14/S.Con.Res. 7 (Establishing the congressional budget for the United States Government for fiscal year 2025) and budget reconciliation; H.R. 1968, Full-Year Continuing Appropriations and Extensions Act, 2025.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.